Cellectar Biosciences

CLRB stock is nicht Shariah-konform

Last updated:

About Cellectar Biosciences (CLRB)

Cellectar Biosciences is a clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for cancer treatment. Its lead phospholipid drug conjugate candidate, CLR 131, is in various clinical studies for relapsed or refractory Waldenstrom's macroglobulinemia, B-cell malignancies, multiple myeloma, and pediatric cancers. The company also has preclinical and collaborative programs for developing other PDC candidates targeting solid tumors and various cancers.

Häufig gestellte Fragen

Is Cellectar Biosciences (CLRB) stock halal to invest in?
As of , CLRB is nicht Shariah-konform and therefore considered halal to invest in. This assessment is based on the data available in Cellectar Biosciences's most recent financial reports.
As of , CLRB is nicht Shariah-konform and therefore not considered halal to invest in. This assessment is based on the data available in Cellectar Biosciences's most recent financial reports.
As of , CLRB is flagged as nicht Shariah-konform in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Cellectar Biosciences's business that require careful consideration.
Does Cellectar Biosciences have any interest income?
Yes, Cellectar Biosciences does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2025, Cellectar Biosciences reported revenue of $0 and interest income of $435,100. The interest income represents 0% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Cellectar Biosciences has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2025, Cellectar Biosciences reported total revenue of 0, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Cellectar Biosciences stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Cellectar Biosciences stock reviewed for Shariah compliance?
The Shariah compliance status of Cellectar Biosciences stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Cellectar Biosciences's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of CLRB, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Cellectar Biosciences stock considered halal?
Yes, dividends from CLRB are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Cellectar Biosciences (CLRB), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from CLRB are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Cellectar Biosciences shares?
If you hold Cellectar Biosciences stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Cellectar Biosciences (CLRB) stock on Zoya

  1. Kostenloses Zoya-Konto erstellen
    Der Einstieg ist ganz einfach. Sie können sich direkt auf unserer Website registrieren oder die Zoya-App für iOS oder Android herunterladen.
  2. Depot verknüpfen
    Zoya arbeitet mit führenden Brokern wie Alpaca und anderen zusammen, damit Sie Aktien nahtlos über Zoya kaufen und verwalten können.
  3. Anlagebetrag festlegen
    Öffnen Sie die Suche und geben Sie den Namen der Aktie in die Suchleiste ein. Klicken Sie anschließend auf die Schaltfläche „Kaufen“ und geben Sie den Betrag ein, den Sie investieren möchten – entweder in Dollar oder als Anzahl der Anteile. Prüfen Sie den aktuellen Aktienkurs und die geschätzte Anzahl der Anteile, bevor Sie Ihre Investition bestätigen.
  4. Ihr Portfolio an einem Ort verwalten
    Ihre neu gekaufte Aktie finden Sie zusammen mit Ihren übrigen Positionen in Ihrem Zoya-Portfolio. Aktivieren Sie Benachrichtigungen, um über Änderungen der Shariah-Konformität Ihres Portfolios informiert zu werden.

Community posts

Ähnliche Aktien

See how Cellectar Biosciences compares with its peers:
Shariah compliance data powered by the Zoya API. Chart by TradingView